Real-world efficacy of stapokibart for severe olfactory dysfunction: early and sustained improvement independent of baseline type 2 inflammation status and nasal polyp burden - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Real-World Assessment of Stapokibart's Effectiveness for Severe Olfactory Dysfunction: Early and Lasting Improvements Regardless of Initial Type 2 Inflammation Levels and Nasal Polyp Severity

  • By

  • Xiang-Ning Cheng

  • Liu-Qing Zhou

  • Yue Zhou

  • Sha-Zhou Li

  • Shan Chen

  • Qing Cheng

  • Li-Yue Li

  • Jian-Jun Chen

  • Tao Zhou

  • June 11, 2026

Share

Original Source(s)

Real-world efficacy of stapokibart for severe olfactory dysfunction: early and sustained improvement independent of baseline type 2 inflammation status and nasal polyp burden

  • by Xiang-Ning Cheng, Liu-Qing Zhou, Yue Zhou, Sha-Zhou Li, Shan Chen, Qing Cheng, Li-Yue Li, Jian-Jun Chen, Tao Zhou

  • June 11, 2026

Related Content

Higher Steroid Exposure Linked to Systemic Adverse Events in CRSwNP

Higher annual oral corticosteroid exposure was associated with greater odds of systemic adverse events, with avascular bone necrosis and pneumonia showing dose-dependent associations with cumulative dose and osteoporosis associated with longer annual exposure duration.

Medical Oddities: Brain Health, Sunny-Side Up

Breakfast, bacteria, and brain wiring—small things show big implications this week.

Diagnostic value and immune microenvironment regulatory network of metabolic reprogramming in chronic rhinosinusitis with nasal polyps identified by multidimensional transcriptome integration and machine learning